Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to FOLFIRINOX
Related studies linked through entity extraction aliases.
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
- Status
- RECRUITING
- Phase
- N/A
NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
- Status
- RECRUITING
- Phase
- PHASE3
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
FOLFIRINOX + NIS793 in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Brazilian Total Neoadjuvant Therapy Trial
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pancreatic Adenocarcinoma Signature Stratification for Treatment
- Status
- COMPLETED
- Phase
- PHASE2
ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Systemic Chemotherapy Plus PD-1 for Metastasis ICC
- Status
- WITHDRAWN
- Phase
- PHASE2